Respiratory Syncytial Virus Infections
"Respiratory Syncytial Virus Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.
| Descriptor ID |
D018357
|
| MeSH Number(s) |
C02.782.580.600.620.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Respiratory Syncytial Virus Infections".
Below are MeSH descriptors whose meaning is more specific than "Respiratory Syncytial Virus Infections".
This graph shows the total number of publications written about "Respiratory Syncytial Virus Infections" by people in this website by year, and whether "Respiratory Syncytial Virus Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Respiratory Syncytial Virus Infections" by people in Profiles.
-
Ahmad A, Majaz S, Saeed A, Noreen S, Abbas M, Khan B, Rahman HU, Nouroz F, Xie Y, Rashid A, Rehman AU. Microevolution and phylogenomic study of Respiratory Syncytial Virus type A. PLoS One. 2025; 20(2):e0319437.
-
Bender W, Zhang Y, Corbett A, Chu C, Grier A, Wang L, Qiu X, McCall MN, Topham DJ, Walsh EE, Mariani TJ, Scheuermann R, Caserta MT, Anderson CS. Association of disease severity and genetic variation during primary Respiratory Syncytial Virus infections. BMC Med Genomics. 2024 06 19; 17(1):165.
-
Joerger T, Chan S, Swami SK, Handy LK. Impact of an Antimicrobial Stewardship Policy to Restrict Palivizumab Use. J Pediatric Infect Dis Soc. 2019 May 11; 8(2):189-190.
-
Tavsu I, Gursoy T, Dirman S, Erbil N, Ovali F. Palivizumab prophylaxis: does it have any influence on the growth and development of the infants? Am J Perinatol. 2014 Sep; 31(8):667-72.
-
Delgado MF, Coviello S, Monsalvo AC, Melendi GA, Hernandez JZ, Batalle JP, Diaz L, Trento A, Chang HY, Mitzner W, Ravetch J, Melero JA, Irusta PM, Polack FP. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med. 2009 Jan; 15(1):34-41.
-
Durani Y, Friedman MJ, Attia MW. Clinical predictors of respiratory syncytial virus infection in children. Pediatr Int. 2008 Jun; 50(3):352-5.
-
Moore FO, Berne JD, Slamon NB, Penfil SH, Dunn SP. Intussusception in a child with respiratory syncytial virus: a new association. Del Med J. 2006 May; 78(5):185-7.
-
Friedman MJ, Attia MW. Influenza a in young children with suspected respiratory syncytial virus infection. Acad Emerg Med. 2003 Dec; 10(12):1400-3.
-
Paul DA, Leef KH, Chidekel A, Tran K, Eppes S, Stefano JL. Home delivery of palivizumab: outcomes and compliance in regional preterm infants. Del Med J. 2002 Jan; 74(1):11-5.
-
Lofland JH, O'Connor JP, Chatterton ML, Moxey ED, Paddock LE, Nash DB, Desai SA. Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis. Clin Ther. 2000 Nov; 22(11):1357-69.